Prognostic value of HLA-I homozygosity in patients with non-small cell lung cancer treated with single agent immunotherapy
Background We aimed to assess the impact of genomic human leukocyte antigen (HLA)-I/II homozygosity on the survival benefit of patients with unresectable locally advanced, metastatic non-small lung cancer treated by single-agent programmed cell death protein-1/programmed death ligand 1 (PD1/PDL1) in...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
2020-10-01
|
| Colección: | Journal for ImmunoTherapy of Cancer |
| Acceso en línea: | https://jitc.bmj.com/content/8/2/e001620.full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|